CPhI’s Pharma IPR conference is leading destination for IP professionals from leading Indian pharma companies and global law firms. Now in its 6th year, the Pharma IPR conference promises to be the biggest IP platform with over 250 thought leader to discuss the burning issues faced by the Indian Pharma Industry.

In the past 5 years this forum has seen participation from 150 pharma companies and law firms from US, Europe, China, Japan, Brazil, Taiwan, Canada, GCC, India, South Africa and many more. This conference is also an established networking platform where pharma companies meet international law firms to build long lasting business relations.

IPR 2016

Key Highlights for IPR 2017

Sessions focussing on:
  • Ammendments in Abbreviated New Drug Applications and 505(b)(2) Applications
  • Implications of Brexit on Indian Pharma
  • Evaluating IP enforcements in China
  • Biosimilars patent laws in US and EU

Discussions on patent case laws of over 10 countries by Indian and International experts Panel Discussions for in depth learning, covering key aspects of patents, trademarks and copyrights Moot Court


Event Partners


Gold Partners

Cocktail Partners

Silver Partners

Bronze Partner

Session Partners

Technology Partner

Associate Partner

Exhibit Partner

Media Partners